These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1801354)

  • 81. Intradermal inoculation with Heptavax-B. Immune response and histologic evaluation of injection sites.
    Clarke JA; Hollinger FB; Lewis E; Russell LA; Miller CH; Huntley A; Flynn NM
    JAMA; 1989 Nov; 262(18):2567-71. PubMed ID: 2530364
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial.
    Han B; Liu W; Du J; Liu H; Zhao T; Yang S; Wang S; Zhang S; Liu B; Liu Y; Cui F
    Vaccine; 2021 Jun; 39(25):3365-3371. PubMed ID: 33992438
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation.
    Yap I; Chan SH
    Ann Acad Med Singap; 1996 Jan; 25(1):120-2. PubMed ID: 8779530
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immunogenicity of low doses of hepatitis B vaccine in normal children.
    Matsaniotis N; Kattamis C; Dionyssopouolou E; Laskari S
    Vaccine; 1985 Sep; 3(3):297-9. PubMed ID: 3904258
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunological response to two hepatitis B vaccines administered in two different schedules.
    Girisha KM; Kamat JR; Nataraj G
    Indian J Pediatr; 2006 Jun; 73(6):489-91. PubMed ID: 16816509
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical evaluation of a yeast recombinant hepatitis B vaccine in healthy hospital staff in Singapore.
    Oon CJ; Guan R; Wong-Yong LY; Smith R
    Ann Acad Med Singap; 1988 Apr; 17(2):185-9. PubMed ID: 3044257
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunoprophylaxis to limit a hepatitis B epidemic among women undergoing in vitro fertilization.
    Grosheide PM; van Osand HC; Schalm SW; Heijtink RA
    Vaccine; 1991 Sep; 9(9):682-7. PubMed ID: 1835229
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hepatitis B virus infection and vaccination in children undergoing hemodialysis.
    Callis LM; Clanxet J; Fortuny G; Caballeria J; Carrasco JL; Lardinois R
    Acta Paediatr Scand; 1985 Mar; 74(2):213-8. PubMed ID: 3993367
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).
    Fujisawa Y; Kuroda S; Van Eerd PM; Schellekens H; Kakinuma A
    Vaccine; 1990 Jun; 8(3):192-8. PubMed ID: 2363298
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Comparative studies on immunogenicity of Chinese hamster ovary cell derived HB vaccine and plasma derived HB vaccine].
    Yagura M; Kamitsukasa H; Harada H; Ohbayashi A
    Kansenshogaku Zasshi; 1991 May; 65(5):577-85. PubMed ID: 1880449
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Preimmunisation hepatitis B screening in Singapore--a viewpoint from private sector clinics.
    Mah GK; Yeo A
    Ann Acad Med Singap; 1990 May; 19(3):339-43. PubMed ID: 2144101
    [TBL] [Abstract][Full Text] [Related]  

  • 92. New vaccines against hepatitis B.
    Papaevangelou G; Roumeliotou-Karayannis A
    Eur J Epidemiol; 1987 Mar; 3(1):1-4. PubMed ID: 2953625
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Results of immunisation with a recombinant yeast-derived hepatitis B vaccine.
    Jilg W; Deinhardt F
    J Infect; 1986 Jul; 13 Suppl A():47-51. PubMed ID: 2943815
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hepatitis B vaccination and immune response in children with malignant diseases.
    Entacher U; Jürgenssen O; Thun-Hohenstein L; Simbruner G; Khoss A; Wank H; Neuwirth G; Gadner H; Frisch-Niggemeyer W
    Eur J Pediatr; 1985 Jul; 144(2):160-3. PubMed ID: 4043127
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Some concern over instituting hepatitis B vaccine into babies' routine vaccination schedules.
    Infect Control Hosp Epidemiol; 1991 Dec; 12(12):745-6. PubMed ID: 1813584
    [No Abstract]   [Full Text] [Related]  

  • 96. Safety and immunogenicity of hepatitis B vaccine ButaNG in adults.
    Ioshimoto LM; Rissato ML; Bonilha VS; Miyaki C; Raw I; Granovski N
    Rev Inst Med Trop Sao Paulo; 1999 May; 41(3):191-3. PubMed ID: 10529840
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A randomized controlled trial of two schedules of hepatitis B vaccination in predialysed chronic renal failure patients.
    Ahmadi F; Ramezani M; Razeghi E; Ranjbarnovin N; Khazaeipour Z
    Hepat Mon; 2012 May; 12(5):344-8. PubMed ID: 22783347
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The test for hepatitis B surface antigen is transiently positive after vaccination with recombinant vaccine.
    Brodersen HP; Beckers B; Köhler H; Dahlmanns C; Kruska L; Larbig D
    Nephrol Dial Transplant; 1997 Dec; 12(12):2756-7. PubMed ID: 9430890
    [No Abstract]   [Full Text] [Related]  

  • 99. One year evaluation of immunogenicity conferred by a Chinese hamster ovary cell recombinant hepatitis B vaccine in a French Polynesian newborn immunization programme.
    Spiegel A; Boutin JP; Cartel JL; Chanteau S; Cardines R; Saliou P; Roux JF
    Trans R Soc Trop Med Hyg; 1991; 85(6):783-7. PubMed ID: 1801354
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A 5-year immunization field trial against hepatitis B using a Chinese hamster ovary cell recombinant vaccine in French Polynesian newborns: results at 3 years.
    Moulia-Pelat JP; Spiegel A; Martin PM; Cardines R; Boutin JP; Roux JF; Excler JL; Saliou P
    Vaccine; 1994 May; 12(6):499-502. PubMed ID: 8036822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.